Drugs Made In America Acquisition (DMIIR) Net Income towards Common Stockholders (2025 - 2026)
Drugs Made In America Acquisition (DMIIR) posted quarterly Net Income towards Common Stockholders of $2.1 million for Q4 2025, up 25270.18% quarter-over-quarter from -$8207.0 in Q3 2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIR) Net Income towards Common Stockholders (2025 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Net Income towards Common Stockholders for 1 consecutive years, with $2.1 million the latest figure, recorded in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | -8,222.00 |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | - |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - | 1.88 Mn |
| 4 | Armada Acquisition | 666.55 Mn | 666.49 Mn | - | -503,862.00 |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - | -177,258.00 |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - | 1.69 Mn |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - | -481,615.00 |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - | 1.38 Mn |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - | 1.28 Mn |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - | 3.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.45 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | -37,951.00 |